Bilal Ahmed, Muhammad Iqbal Tareen, Ashok Kumar, Saira Baloch, Hazir Rehman, Zahid Mustafa, Abdul Malik Tareen.
An effective combined therapy of meglumine antimoniate and co-trimoxazole for cutaneous leishmaniasis: A study in Quetta City.
J Pak Assoc Derma Jan ;24(2):122-6.

Objective: To evaluate the efficacy of combined therapy of meglumine antimoniate and co-trimoxazole in cutaneous leishmaniasis (CL). Methods: 180 patients with active lesions of CL, confirmed by fine needle aspiration cytology (FNAC) were treated with combined therapy of meglumine antimoniate (Glucantime) and co-trimoxazole (Septran) for 20 days. Results: Out of 180 patients, 160 (88.9%) were cured. A few patients reported nausea, vomiting, glossitis, skin rashes and folate deficiency. Conclusion: The combined therapy of meglumine antimoniate (Glucantime) and co-trimoxazole (Septran) is more effective than the previously reported combined therapies.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com